Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Eloxx to Test Its Lead Product Candidate, ELX-02, In Rare Kidney Disease
Eloxx Pharmaceuticals Inc (NASDAQ: ELOX)
Eloxx Pharmaceuticals Q4 EPS $(0.14) Misses $(0.12) Estimate
Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.12) by 16.67 percent. This is a 6.67 percent increase over losses of $(0.15) per share
Eloxx Pharma Wins $15.9M Grant From Cystic Fibrosis Foundation
Cystic Fibrosis Foundation (CF Foundation) to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program
Expect topline data from cystic fibrosis Phase 2 expansion treatment arms evaluating
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
65 Biggest Movers From Yesterday
Gainers
Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.
25 Stocks Moving in Monday’s Pre-Market Session
Gainers
Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index.